Results 11 to 20 of about 11,489 (185)

FGF23, Biomarker or Target?

open access: yesToxins, 2019
Fibroblast growth factor 23 (FGF23) plays a key role in the complex network between the bones and other organs. Initially, it was thought that FGF23 exclusively regulated phosphate and vitamin D metabolism; however, recent research has demonstrated that ...
Rafael Santamaría   +2 more
exaly   +3 more sources

ERRγ-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress

open access: yesRedox Biology
Fibroblast growth factor 23 (FGF23) is a member of endocrine FGF family, along with FGF15/19 and FGF21. Recent reports showed that under pathological conditions, liver produces FGF23, although the role of hepatic FGF23 remains nebulous.
Hueng-Sik Choi, Yoon Seok Jung
exaly   +3 more sources

The Binding of Fibroblast Growth Factor 23 (FGF23) to FGF Receptor-αKlotho Complex Increases Sinoatrial Electrical Activity. [PDF]

open access: yesActa Physiol (Oxf)
ABSTRACT Aim This study aims to investigate whether the Fibroblast Growth Factor 23 (FGF23) modulates the electrical activity of sinoatrial (SAN) cells. The canonical function of FGF23 is to regulate body phosphorus and calcium homeostasis by activating the FGF1 receptors (FGFR1)/α‐Klotho complex in the kidney and parathyroid glands.
Bertoli G   +10 more
europepmc   +2 more sources

FGF23 signalling and physiology [PDF]

open access: yesJournal of Molecular Endocrinology, 2021
Fibroblast growth factor 23 (FGF23) is a phosphotropic hormone that belongs to a subfamily of endocrine FGFs with evolutionarily conserved functions in worms and fruit flies. FAM20C phosphorylates FGF23 post-translationally, targeting it to proteolysis through subtilisin-like proprotein convertase FURIN, resulting in secretion of FGF23 fragments.
Bryan B, Ho, Clemens, Bergwitz
openaire   +2 more sources

Higher maternal parathyroid hormone concentration at delivery is not associated with smaller newborn size

open access: yesEndocrine Connections, 2021
Intrauterine growth restriction (IUGR) reflects inadequate growth in-utero and is prevalent in low resource settings. This study aimed to assess the association of maternal delivery parathyroid hormone (PTH) – a regulator of bone turnover and calcium ...
Huma Qamar   +5 more
doaj   +1 more source

FGF23 promotes atrial fibrillation susceptibility through ETV1-dependent sodium channel regulation and calcium handling abnormalities. [PDF]

open access: yesExp Physiol
Abstract Fibroblast growth factor 23 (FGF23) is closely associated with atrial fibrillation (AF), yet whether it modulates sodium and calcium currents in atrial myocytes remains unclear. ETV1, a key transcription factor regulating atrial electrical conduction, might also be involved in FGF23‐mediated AF.
Yu Q   +7 more
europepmc   +2 more sources

Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia

open access: yesBone Reports, 2023
While the positive association between automated intact fibroblast growth factor (FGF) 23 measurement kit (Determinar CL FGF23 [CL]) and the former assay (Kainos [KI]), and clinical utility of CL was well established, the clinical performance of ...
Hajime Kato   +8 more
doaj   +1 more source

Promotion effect of FGF23 on osteopenia in congenital scoliosis through FGFr3/TNAP/OPN pathway

open access: yesChinese Medical Journal, 2023
. Background:. Congenital scoliosis (CS) is a complex spinal malformation of unknown etiology with abnormal bone metabolism. Fibroblast growth factor 23 (FGF23), secreted by osteoblasts and osteocytes, can inhibit bone formation and mineralization. This
Hongqi Zhang   +8 more
doaj   +1 more source

αKlotho: FGF23 coreceptor and FGF23-regulating hormone [PDF]

open access: yesJournal of Clinical Investigation, 2012
Low levels of phosphate can disrupt bone ossification and predispose to fractures. FGF23 is one of the major determinants of phosphate homeostasis, acting to increase urinary phosphate excretion. However, the regulation of FGF23 is incompletely understood. In this issue of the JCI, Smith et al.
Harald, Jüppner, Myles, Wolf
openaire   +2 more sources

Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list. [PDF]

open access: yesPLoS ONE, 2013
High plasma fibroblast growth factor-23 (FGF23) concentration predicts the risk of death and poor outcomes in patients with chronic kidney disease or chronic heart failure.
Dominique Prié   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy